Dermata Therapeutics, Inc. (DRMA) News
Follow Dermata Therapeutics, Inc. (DRMA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Dermata Therapeutics announces $3.4M at-the-market private placement
Dermata Therapeutics (DRMA) announces a $3.4 million private placement priced at-the-market under Nasdaq rules, with details not provided in the feed.
REGULATION | Aug 17, 2026, 12:30 PM UTC
H
Premarket Top Gainers: BAOS Leads
BAOS gains 175.66% in premarket trading, leading the top ten gainers
EQUITY | Aug 12, 2026, 09:30 AM UTC
L
DRMA Leads Health Care Gainers
Dermata Therapeutics stock rises 44.4% to $1.56 after Q2 earnings report
EARNINGS | Aug 11, 2026, 09:06 PM UTC
L
Dermata Therapeutics Q2 EPS $(0.74) Misses $(0.55) Estimate
Dermata Therapeutics Q2 EPS $(0.74) Misses $(0.55) Estimate
EARNINGS | Aug 11, 2026, 08:37 PM UTC
H
Dermata Launches Tome Foundational Treatment
Dermata launches Tome treatment commercially
EQUITY | Aug 05, 2026, 12:30 PM UTC